Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin‐releasing hormone receptor‐dependent mechanism

Serotonin is important for adequate coping with stress. Aberrant serotonin function is implicated in the aetiology of major depression and anxiety disorders. Dysregulation of the hypothalamic–pituitary–adrenocortical axis, involving elevated corticotropin‐releasing hormone (CRH) activity, also plays a role in these stress‐related illnesses. Here we studied the effects of stress on hippocampal serotonin and the role of the CRH system using in vivo microdialysis. First, rats were subjected to a forced swim stress, resulting in a dramatic increase in hippocampal serotonin (1500% of baseline), which was associated with the occurrence of diving behaviour. The diving‐associated increase in serotonin depended on activation of CRH receptors, as it was antagonized by intracerebroventricular pretreatment with D‐Phe‐CRH12−41. Secondly, the effects of intracerebroventricular administration of CRH and urocortin (0.03–1.0 µg) were studied. Both CRH and urocortin caused a dose‐dependent rise in hippocampal serotonin (maximally 350% of baseline) and 5‐hydroxyindoleacetic acid levels, suggesting the involvement of CRH receptor type 1. Because the effects of urocortin were prolonged, CRH receptor type 2 could play a role in a later phase of the neurotransmitter response. Experiments using adrenalectomized rats showed that CRH‐induced serotonin changes were adrenally independent. These data suggest that the raphe‐hippocampal serotonin system is able to mount, CRH receptor‐dependent, responses to specific stressful situations that surpass the usually observed maximal increases of about 300% of baseline during stress and enhanced vigilance.

[1]  F. Holsboer,et al.  Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. , 2002, Current opinion in pharmacology.

[2]  C. Flachskamm,et al.  Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice , 2002, Neuroscience.

[3]  P. Celada,et al.  Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors , 2001, The Journal of Neuroscience.

[4]  E. V. Van Bockstaele,et al.  Evidence for regional heterogeneity in corticotropin‐releasing factor interactions in the dorsal raphe nucleus , 2001, The Journal of comparative neurology.

[5]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Heinrichs,et al.  The role of CRH in behavioral responses to stress , 2001, Peptides.

[7]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[8]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[10]  S. Lightman,et al.  Corticotropin-Releasing Factor Increases In VitroFiring Rates of Serotonergic Neurons in the Rat Dorsal Raphe Nucleus: Evidence for Activation of a Topographically Organized Mesolimbocortical Serotonergic System , 2000, The Journal of Neuroscience.

[11]  J. Akiyoshi,et al.  Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo , 2000, Neuropeptides.

[12]  M. Hajós,et al.  Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons , 2000, Neuroscience.

[13]  S. File,et al.  The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety , 2000, Pharmacology Biochemistry and Behavior.

[14]  F. Chaouloff Serotonin, stress and corticoids , 2000, Journal of psychopharmacology.

[15]  R. Tao,et al.  Regulation of serotonin release by GABA and excitatory amino acids , 2000, Journal of psychopharmacology.

[16]  K. Rice,et al.  Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus , 2000, Neuropsychopharmacology.

[17]  P. Sawchenko,et al.  Do Centrally Administered Neuropeptides Access Cognate Receptors?: An Analysis in the Central Corticotropin-Releasing Factor System , 2000, The Journal of Neuroscience.

[18]  C. Flachskamm,et al.  Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice , 2000, The European journal of neuroscience.

[19]  J. Vaughan,et al.  Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors , 1999, The Journal of comparative neurology.

[20]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[21]  B. Jacobs,et al.  Activity of Serotonergic Neurons in Behaving Animals , 1999, Neuropsychopharmacology.

[22]  F. Holsboer,et al.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. , 1999, Journal of psychiatric research.

[23]  J. Herbert,et al.  Central serotonin depletion modulates the behavioural, endocrine and physiological responses to repeated social stress and subsequent c-fos expression in the brains of male rats , 1999, Neuroscience.

[24]  A. Shekhar,et al.  Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses , 1999, Behavioural Brain Research.

[25]  E. Eriksson,et al.  Effects of mCPP on the Extracellular Concentrations of Serotonin and Dopamine in Rat Brain , 1999, Neuropsychopharmacology.

[26]  G. Griebel,et al.  Benzodiazepine and Serotonergic Modulation of Antipredator and Conspecific Defense , 1998, Neuroscience & Biobehavioral Reviews.

[27]  J. Hagan,et al.  The behavioural effects of corticotropin-releasing factor-related peptides in rats , 1998, Psychopharmacology.

[28]  M. Hajós,et al.  An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat , 1998, Neuroscience.

[29]  S. Maier,et al.  Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat , 1998, Brain Research.

[30]  I. Lucki,et al.  Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity , 1998, Neuropsychopharmacology.

[31]  A. Arimura,et al.  Distribution of urocortin‐like immunoreactivity in the central nervous system of the rat , 1998, The Journal of comparative neurology.

[32]  C. Rampon,et al.  Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods , 1997, Neuroscience.

[33]  Florian Holsboer,et al.  Long-Term Intracerebroventricular Infusion of Corticotropin-Releasing Hormone Alters Neuroendocrine, Neurochemical, Autonomic, Behavioral, and Cytokine Responses to a Systemic Inflammatory Challenge , 1997, The Journal of Neuroscience.

[34]  F. Artigas,et al.  Comparative Study in the Rat of the Actions of Different Types of Stress on the Release of 5-HT in Raphe Nuclei and Forebrain Areas , 1997, Neuropharmacology.

[35]  B. Jacobs,et al.  A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations , 1996, Brain Research.

[36]  C. Donaldson Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896] , 1996 .

[37]  C. Donaldson,et al.  Cloning and characterization of human urocortin. , 1996, Endocrinology.

[38]  B. Jacobs,et al.  A subgroup of dorsal raphe serotonergic neurons in the cat is strongly activated during oral-buccal movements , 1996, Brain Research.

[39]  F. Holsboer,et al.  Antidepressants and hypothalamic-pituitary-adrenocortical regulation. , 1996, Endocrine reviews.

[40]  R. Fuller Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats , 1995, Behavioural Brain Research.

[41]  C. Flachskamm,et al.  Intraperitoneal Administration of Bacterial Endotoxin Enhances Noradrenergic Neurotransmission in the Rat Preoptic Area: Relationship with Body Temperature and Hypothalamic‐Pituitary‐Adrenocortical Axis Activity , 1995, The European journal of neuroscience.

[42]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[43]  E. De Souza,et al.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  I. Lucki,et al.  Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid , 1995, Brain Research.

[45]  P. Müller-Preuss,et al.  Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  T. Lovenberg,et al.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[48]  M. Fillenz,et al.  Comparison of Stress‐induced Changes in Noradrenergic and Serotonergic Neurons in the Rat Hippocampus Using Microdialysis , 1994, The European journal of neuroscience.

[49]  E. Azmitia,et al.  Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  M. Baumann,et al.  Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats , 1993, Neuropharmacology.

[51]  S. Maier,et al.  The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. , 1993, Behavioral neuroscience.

[52]  W. Hesen,et al.  Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  L. Wiklund,et al.  Afferents to the median raphe nucleus of the rat: Retrograde cholera toxin and wheat germ conjugated horseradish peroxidase tracing, and selectived-[3H]aspartate labelling of possible excitatory amino acid inputs , 1990, Neuroscience.

[54]  T. Phan,et al.  Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment , 1990, Brain Research.

[55]  Craig W. Berridge,et al.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? , 1990, Brain Research Reviews.

[56]  A. Björklund,et al.  Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail‐Pinch , 1989, The European journal of neuroscience.

[57]  R. Kahn,et al.  Behavioral indications for serotonin receptor hypersensitivity in panic disorder , 1988, Psychiatry Research.

[58]  M. Sakanaka,et al.  Corticotropin releasing factor‐like immunoreactivity in the rat brain as revealed by a modified cobalt‐glucose oxidase‐diaminobenzidine method , 1987, The Journal of comparative neurology.

[59]  C. Kilts,et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.

[60]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[61]  G. Aghajanian,et al.  Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique , 1977, Brain Research.

[62]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[63]  B. Jacobs,et al.  Structure and function of the brain serotonin system. , 1992, Physiological reviews.

[64]  L. Swanson,et al.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. , 1983, Neuroendocrinology.